Literature DB >> 18502489

Lactate production and neurotransmitters; evidence from microdialysis studies.

Takashi Uehara1, Tomiki Sumiyoshi, Hiroko Itoh, Koichi Kurata.   

Abstract

Recent studies have found that lactate metabolism plays a significant role in energy supply during acute neural activation in the brain. We will review evidence from microdialysis studies for a relationship between neurotransmitters and lactate production, as revealed in studies of the effects of psychotropic drugs on stress-induced enhancement of extracellular lactate concentrations. Glutamate enhances stress-induced lactate production via activation of N-methyl-D-asparate receptors, and is affected by uptake of glutamate through glutamate transporters. Findings from microdialysis studies suggest that major neurotransmitters, including norepinephrine, dopamine, serotonin, and GABA (via benzodiazepine-receptors) affect lactate production, depending on brain areas, especially during stress. Among these neurotransmitters, glutamate may principally contribute to the regulation of lactate production, with other neurotransmitter systems affecting the extracellular lactate levels in a glutamate-mediated manner. The role for anaerobic metabolism in the supply of energy, as represented by lactate dynamics, deserves further clarification. Monitoring with intracerebral microdialysis is a reliable method for this purpose. Research into this area is likely to provide a novel insight into the mode of action of psychotropic drugs, and the pathophysiology of some of the stress-related mental disorders as well.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502489     DOI: 10.1016/j.pbb.2008.04.001

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo.

Authors:  Shannon L Macauley; Molly Stanley; Emily E Caesar; Steven A Yamada; Marcus E Raichle; Ronaldo Perez; Thomas E Mahan; Courtney L Sutphen; David M Holtzman
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 2.  Metabolic sensing and the brain: who, what, where, and how?

Authors:  Barry E Levin; Christophe Magnan; Ambrose Dunn-Meynell; Christelle Le Foll
Journal:  Endocrinology       Date:  2011-04-26       Impact factor: 4.736

3.  Simultaneous detection of cerebral metabolism of different substrates by in vivo ¹³C isotopomer MRS.

Authors:  Yun Xiang; Jun Shen
Journal:  J Neurosci Methods       Date:  2011-03-16       Impact factor: 2.390

4.  Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model.

Authors:  Fan Liao; Tony J Zhang; Thomas E Mahan; Hong Jiang; David M Holtzman
Journal:  Brain Behav Immun       Date:  2014-09-16       Impact factor: 7.217

5.  Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology.

Authors:  Jee Hoon Roh; Yafei Huang; Adam W Bero; Tom Kasten; Floy R Stewart; Randall J Bateman; David M Holtzman
Journal:  Sci Transl Med       Date:  2012-09-05       Impact factor: 17.956

6.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition.

Authors:  Adam W Bero; Ping Yan; Jee Hoon Roh; John R Cirrito; Floy R Stewart; Marcus E Raichle; Jin-Moo Lee; David M Holtzman
Journal:  Nat Neurosci       Date:  2011-05-01       Impact factor: 24.884

7.  Is lactate a volume transmitter of metabolic states of the brain?

Authors:  Linda H Bergersen; Albert Gjedde
Journal:  Front Neuroenergetics       Date:  2012-03-19

8.  Tandospirone, a 5-HT1A partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the therapeutics of cognitive impairment of schizophrenia.

Authors:  Takashi Uehara; Tadasu Matsuoka; Tomiki Sumiyoshi
Journal:  Front Behav Neurosci       Date:  2014-09-03       Impact factor: 3.558

Review 9.  New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Masayoshi Kurachi
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 10.  Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia.

Authors:  Tomiki Sumiyoshi; Yuko Higuchi; Takashi Uehara
Journal:  Front Behav Neurosci       Date:  2013-10-16       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.